XML 64 R47.htm IDEA: XBRL DOCUMENT v3.25.0.1
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of compensation cost for share-based payment arrangements, allocation of share-based compensation costs by plan
The following table details our share-based compensation expense related to award grants to our officers, directors, and employees. We recognized $7 million, $7 million, and $6 million of tax benefits associated with share-based compensation during 2024, 2023, and 2022, respectively.
($ in millions)202420232022
Service-based RSUs$30 $29 $31 
Performance-based RSUs— — 
30 29 34 
SARs
$33 $31 $39 
Schedule of unrecognized compensation cost, unvested awards
The following table details our deferred compensation costs related to unvested awards:
($ in millions)
At Year-End 2024(1)
At Year-End 2023
Service-based RSUs$24 $22 
Performance-based RSUs
29 23 
SARs
$30 $24 
(1)As of December 31, 2024, the weighted average remaining term for RSU grants outstanding at year-end 2024 was one to three years and we expect that deferred compensation expense will be recognized over a weighted average period of one to three years.
Schedule of outstanding RSUs and the associated weighted average grant-date fair values
The following table shows the changes in our outstanding RSUs and the associated weighted average grant-date fair values:
2024
Service-basedPerformance-basedTotal
Number of RSUsWeighted Average Grant-Date Fair Value Per RSUNumber of RSUsWeighted Average Grant-Date Fair Value Per RSUNumber of RSUsWeighted Average Grant-Date Fair Value Per RSU
Outstanding at year-end 2023655,114$123.91 192,724$148.29 847,838$129.45 
Granted403,071$87.54 204,020$85.12 607,091$86.73 
Distributed(249,097)$134.08 $— (249,097)$134.08 
Forfeited(25,561)$107.54 (20,912)$109.86 (46,473)$108.59 
Outstanding at year-end 2024783,527$102.50 375,832$116.13 1,159,359$106.92 
Schedule of outstanding SARs and the associated weighted average exercise prices
The following table shows the changes in our outstanding SARs and the associated weighted average exercise prices: 
 2024
 Number of
SARs
Weighted Average Exercise Price Per SAR
Outstanding at year-end 2023720,028$116.56 
Granted86,759 $93.73 
Exercised(45,022)$73.65 
Forfeited or expired(3,036)$93.73 
Outstanding at year-end 2024(1)(2)
758,729$116.59 
(1)As of December 31, 2024, outstanding SARs had an aggregate intrinsic value of $3 million and a weighted average remaining term of 5 years.
(2)As of December 31, 2024, 580,534 SARs with a weighted average exercise price of $112.42, an aggregate intrinsic value of $3 million and a weighted average remaining contractual term of 4 years were exercisable.
Assumptions used to estimate fair value of grants
The following table outlines the assumptions used to estimate the fair value of grants in 2024, 2023, and 2022:
202420232022
Expected volatility45.78%40.47%42.86%
Dividend yield3.21%1.87%1.53%
Risk-free rate4.23%4.07%1.77%
Expected term (in years)6.256.256.25